Biden Moves Momentum of Big Government to Cancer Patients
This week the president renewed his determination to bring the resources of the federal government to the side of patients. This was a welcome move in 2016, and it is welcome today. The government must step in where the free market is failing. This year has seen a punishing market downturn after a pandemic run on biotech and genomics stocks, and the president's support can provide a much needed shot in the arm for the therapeutic and diagnostic industries.
